Click on any category below to view a list of applications.
	Clinical Immunology Clinical Markers Cytokines and Chemokines High-Throughput Screening Metabolic Phosphoproteins, Intracellular Signaling, and Apoptosis Technology Ubiquitin Full List
New Applications NEW: Multiplex Analysis of Akt/mTOR and JAK/STAT Signaling Pathways NEW: Development of MULTI-ARRAY® and MULTI-SPOT® Immunoassays for Cell Cycle Targets New Toxicology Applications NEW: Qualification of MSD’s Argutus AKI Test® for Preclinical Studies NEW: Qualification of Multiplexed Cardiac Injury Markers for Preclinical Studies NEW: Rat Cytokines and Acute Phase Protein Multiplexes for Preclinical Toxicology NEW: Qualification of Kidney Injury Markers for Preclinical Studies NEW: Qualification of Steroid Markers for Preclinical Studies NEW: Qualification of Muscle Injury Panel 1 Markers for Preclinical Studies NEW: Qualification of Muscle Injury Panel 2 and Rat Skeletal Troponin I Markers for Preclinical Studies New Oncology Applications NEW: Development of a Multiplexed Immunoassay Panel for Ten Cancer Markers: AFP, Ca125, Ca19-9, CEA, cKit, E-Cadherin, EGFR, ErbB2, MMP-9, & Osteopontin